Advertisement
DALLAS, Dec. 19, 2014 /PRNewswire-iReach/ -- The report "Brain Injury Pipeline Review H2 2014" provides comprehensive information on the therapeutic development for Brain Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Brain Injury and special features on late-stage and discontinued projects. Complete Report is Available @ http://www.rnrmarketresearch.com/brain-injury-pipeline-review-h2-2014-market-report.html .
Photo - http://photos.prnewswire.com/prnh/20141219/165540
When an external mechanical force causes trauma to the brain it is called as brain injury. Brain injury occurs due to a result of blunt force trauma, penetrating wounds or sudden jolt to the head and/or neck. Some forms of brain injury involve stroke, brain damage, traumatic brain injury and acquired brain injury. Brain injury can cause temporary or permanent dysfunction of brain cells. Some of the symptoms of brain injury are headache, fatigue, nausea, vomiting, dizziness, loss of consciousness, and drowsiness. Other symptoms include mood swings, concentration problems, and feelings of depression or anxiousness. People who are at greater risk of brain injury are elderly people, children under the age four and newborns.
Companies discussed in this Brain Injury Pipeline Review H2 2014 report include Acorda Therapeutics, Inc., Biogen Idec Inc., Chiesi Farmaceutici SpA, Faron Pharmaceuticals Oy, Virogenomics, Inc. Order a Purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=250216 .
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
Scope
Number of Products under Development for Brain Injury, H2 2014Number of Products under Development for Brain Injury - Comparative Analysis, H2 2014Number of Products under Development by Companies, H2 2014Number of Products under Investigation by Universities/Institutes, H2 2014Comparative Analysis by Early Stage Development, H2 2014Products under Development by Companies, H2 2014Products under Investigation by Universities/Institutes, H2 2014Brain Injury - Pipeline by Acorda Therapeutics, Inc., H2 2014Brain Injury - Pipeline by Biogen Idec Inc., H2 2014Brain Injury - Pipeline by Chiesi Farmaceutici SpA, H2 2014Brain Injury - Pipeline by Faron Pharmaceuticals Oy, H2 2014Brain Injury - Pipeline by Virogenomics, Inc., H2 2014Assessment by Monotherapy Products, H2 2014Number of Products by Stage and Target, H2 2014Number of Products by Stage and Mechanism of Action, H2 2014Number of Products by Stage and Route of Administration, H2 2014Number of Products by Stage and Molecule Type, H2 2014Brain Injury Therapeutics - Recent Pipeline Updates, H2 2014Brain Injury - Dormant Projects, H2 2014Brain Injury - Discontinued Products, H2 2014
Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=250216 . (This is a premium report priced at US$2000 for a single user License.)
List of Figures
Number of Products under Development for Brain Injury, H2 2014Number of Products under Development for Brain Injury - Comparative Analysis, H2 2014Number of Products under Investigation by Universities/Institutes, H2 2014Comparative Analysis by Early Stage Products, H2 2014Assessment by Monotherapy Products, H2 2014Number of Products by Top 10 Targets, H2 2014Number of Products by Stage and Top 10 Targets, H2 2014Number of Products by Top 10 Mechanism of Actions, H2 2014Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014Number of Products by Top 10 Molecule Types, H2 2014
Explore more reports on Neurology therapeutics industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/neurology-therapeutics .
About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
Media Contact: Ritesh Tiwari, RnR Market Research, +1888391544, [email protected]
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE RnR Market Research
Advertisement
Photo - http://photos.prnewswire.com/prnh/20141219/165540
When an external mechanical force causes trauma to the brain it is called as brain injury. Brain injury occurs due to a result of blunt force trauma, penetrating wounds or sudden jolt to the head and/or neck. Some forms of brain injury involve stroke, brain damage, traumatic brain injury and acquired brain injury. Brain injury can cause temporary or permanent dysfunction of brain cells. Some of the symptoms of brain injury are headache, fatigue, nausea, vomiting, dizziness, loss of consciousness, and drowsiness. Other symptoms include mood swings, concentration problems, and feelings of depression or anxiousness. People who are at greater risk of brain injury are elderly people, children under the age four and newborns.
Companies discussed in this Brain Injury Pipeline Review H2 2014 report include Acorda Therapeutics, Inc., Biogen Idec Inc., Chiesi Farmaceutici SpA, Faron Pharmaceuticals Oy, Virogenomics, Inc. Order a Purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=250216 .
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
Scope
- The report provides a snapshot of the global therapeutic landscape of Brain Injury
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Brain Injury and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Brain Injury products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Brain Injury pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products
Number of Products under Development for Brain Injury, H2 2014Number of Products under Development for Brain Injury - Comparative Analysis, H2 2014Number of Products under Development by Companies, H2 2014Number of Products under Investigation by Universities/Institutes, H2 2014Comparative Analysis by Early Stage Development, H2 2014Products under Development by Companies, H2 2014Products under Investigation by Universities/Institutes, H2 2014Brain Injury - Pipeline by Acorda Therapeutics, Inc., H2 2014Brain Injury - Pipeline by Biogen Idec Inc., H2 2014Brain Injury - Pipeline by Chiesi Farmaceutici SpA, H2 2014Brain Injury - Pipeline by Faron Pharmaceuticals Oy, H2 2014Brain Injury - Pipeline by Virogenomics, Inc., H2 2014Assessment by Monotherapy Products, H2 2014Number of Products by Stage and Target, H2 2014Number of Products by Stage and Mechanism of Action, H2 2014Number of Products by Stage and Route of Administration, H2 2014Number of Products by Stage and Molecule Type, H2 2014Brain Injury Therapeutics - Recent Pipeline Updates, H2 2014Brain Injury - Dormant Projects, H2 2014Brain Injury - Discontinued Products, H2 2014
Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=250216 . (This is a premium report priced at US$2000 for a single user License.)
List of Figures
Number of Products under Development for Brain Injury, H2 2014Number of Products under Development for Brain Injury - Comparative Analysis, H2 2014Number of Products under Investigation by Universities/Institutes, H2 2014Comparative Analysis by Early Stage Products, H2 2014Assessment by Monotherapy Products, H2 2014Number of Products by Top 10 Targets, H2 2014Number of Products by Stage and Top 10 Targets, H2 2014Number of Products by Top 10 Mechanism of Actions, H2 2014Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014Number of Products by Top 10 Molecule Types, H2 2014
Explore more reports on Neurology therapeutics industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/neurology-therapeutics .
About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
Media Contact: Ritesh Tiwari, RnR Market Research, +1888391544, [email protected]
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE RnR Market Research
